Drug Store News

View more issues:

Articles in Sept 27, 2004 issue of Drug Store News

• Winn-Dixie sells Dixie Packers facility
• Impax Laboratories reported that Teva Pharmaceutical Industries launched Impax's omeprazole delayed-release 20 mg capsules, the generic version of AstraZeneca's Prilosec, marketed by Procter & Gamble for the treatment of duodenal/gastric ulcers and ga
• Chain positive about future
• CVS
• Amerifit Nutirition
• Jason Natural Cosmetics
• Albertsons denies privacy violations
• Advance pharmacy's role in health care, Petri urges
  by James Frederick
• Centers for Disease Control and Prevention
• Andrx Corp
• NDCHealth
• Digital pregnancy testers
  by Michael Johnsen
• Coca-Cola Co
• Publications International
• Revamped Eckerd circulars focus on pharmacy—not food
  by Michelle L. Kirsche
• Sammons: spread the word on pharmacy's inherent value
  by Michael Johnsen
• New pro player in pharmacy predicts winning season with service
  by Antoinette Alexander
• Duane Reade rolls out European skin care centers
  by Antoinette Alexander
• Discount visionary Haft dies from heart disease
  by James Frederick
• Albertsons
• In-pharmacy shopper counts on the decline
  by Bernadette Casey
• Schwarz leadership award goes to Vogt
  by James Frederick
• Generics substitution program could save Air Force millions
  by Michelle L. Kirsche
• Vetco
• Mattel and Bendon Publishing International announced a two-year agreement to produce a line of educational workbooks and learning materials based on the Barbie brand
• De-emphasis on food brings focus back to traditional drug store categories
  by Michael Johnsen
• Communicating 'pharmacy first' is aim in courting lost customers
  by Michelle L. Kirsche
• Rite Aid lowers guidance, citing slow pharmacy sales growth
  by Michael Johnsen
• Brooks, Rite Aid duke it out for customers
  by Michelle L. Kirsche
• Pathmark posts 2Q loss, shares drop
• Blistex
• Fleming settles with SEC
• Surveys find support in U.S. for drug importation surging
  by Michael Johnsen
• Sluggish demand dogs Medicare cards
  by James Frederick
• Novartis Pharmaceuticals'
  by Novartis
• United Research Laboratories/Mutual Pharmaceutical Co
• ECRM
• Neutrogena
• Stronger DVD presence for holiday
  by Michelle L. Kirsche
• Meshing two supply networks is post-acquisition job No. 1
  by James Frederick
• RFID technology today: discovering practical uses
  by Michelle L. Kirsche
• Synergies and challenges will abound as supplier relations take new shape
  by Michael Johnsen
• CVS to air Spanish ads
• Poll finds most think drug prices too high
• Winn-Dixie
• On the show floor
• Digital pens and paper show e-prescribing promise
  by Michelle L. Kirsche
• Anchor Bay Entertainment
• Best of breed, not major surgery, is strategy behind new prototype
  by Antoinette Alexander
• 'King Consolidation' creates industry cliffhanger
  by Rob Eder
• Return to health care mission is aim for pharmacy future
  by James Frederick
• Kroger sees drop in 2Q earnings
• PDX
• Kraft Foods
• Fougera
• AutoMed
• California Assembly
• Jerry Boy introduced its new line of portable peanut butter called PB N' Go
• NABP to spotlight importation
• Women reveal drug store preferences
  by Michelle L. Kirsche
• Eli Lilly
• QS/1's
• Del Laboratories
• Jays Foods
• Targeting techno-savvy 'i-moms' key to capturing photo market share
  by Michelle L. Kirsche
• Circular shows sign of what's on the horizon
  by Michelle L. Kirsche
• Mail order gaining on retail pharmacy market share
  by Michael Johnsen
• Coutu: be a customer, shop your store
  by Antoinette Alexander
• NACDS, PCMA voice issues with Part D drug benefit
• NACDS names federal affairs chief
• Harold W. Pratt Award
• Retail cheaper for 90-day prescriptions, Bernauer asserts
  by James Frederick
• Generics growth faces slowdown as fewer drugs are set to lose patents
• Innotech
• Increased private label visibility should bolster loyalty
• Solid foundation for growth made from an old family recipe
  by Rob Eder
• Albertsons to launch 'fresh rescue' plan
• Bayer, Scherino-Plouoh strike deal
• Illegal importation battle deepens
  by Rob Eder
• Pfizer

• 1
• 2